United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump
We will host a half-hour teleconference on
This teleconference is also being webcast and can be accessed via our website at http://ir.unither.com/events.cfm.
Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements regarding the delayed launch of the RemoSynch Implantable System for Remodulin until 2018. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic and other reports filed with the
Remodulin is a registered trademark, and RemoSynch is a trademark, of
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-therapeutics-announces-regulatory-delays-for-remosynch-implantable-pump-300432961.html
News Provided by Acquire Media